Stockreport

Nurix Therapeutics to Participate in RBC Capital Markets Global Healthcare Conference

Nurix Therapeutics, Inc. - Common stock  (NRIX) 
PDF SAN FRANCISCO, May 07, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein modulat [Read more]